The expression of connexin 43 in children with Tetralogy of Fallot

Jacek Kołcz1, Justyna Drukała, Małgorzata Bzowska

  • 1Department of Pediatric Cardiac Surgery, Polish-American Children's Hospital, Collegium Medicum, Jagiellonian University, Wielicka 265, 30-663 Kraków, Poland.

Insights

Abnormalities in Connexin 43 (Cx43) expression and distribution are linked to Tetralogy of Fallot (TOF) in children. Early correction may improve heart function by addressing Cx43 redistribution.

Area of Science:

  • Cardiovascular Biology
  • Developmental Biology
  • Cellular Biology

Background:

  • Abnormalities in Connexin 43 (Cx43) expression and distribution in cardiomyocytes can disrupt heart development and function.
  • Tetralogy of Fallot (TOF) is a common cyanotic congenital heart defect characterized by conotruncal anomalies, right ventricle dysfunction, and arrhythmias.

Purpose of the Study:

  • To investigate age-related changes in Cx43 expression and spatial distribution in cardiomyocytes of children with TOF compared to controls.
  • To understand the role of Cx43 disturbances in TOF pathogenesis and heart maturation.

Main Methods:

  • Confocal microscopy was employed to visualize Cx43 distribution.
  • Flow cytometry was utilized to quantify Cx43 expression levels.
  • Comparison was made between cardiomyocytes from TOF patients and age-matched controls without right ventricular outflow tract pathology.

Main Results:

  • TOF infants showed lower Cx43 expression compared to controls.
  • In TOF hearts, Cx43 was diffusely distributed across the cell surface, indicative of immature tissue, unlike controls where it localized to intercalated disks.
  • Cx43 expression increased with age in TOF patients, but its abnormal spatial distribution persisted.

Conclusions:

  • Disturbed Cx43 expression and localization in TOF may impair heart embryogenesis, maturation, and contribute to right ventricle dysfunction and arrhythmias.
  • Early redistribution of Cx43 and improved cardiac maturation support early surgical correction of TOF.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Gap Junctions01:37

Gap Junctions

Multicellular organisms employ a variety of ways for cells to communicate with each other. Gap junctions are specialized proteins that form pores between neighboring cells in animals, connecting the cytoplasm between the two, and allowing for the exchange of molecules and ions. They are found in a wide range of invertebrate and vertebrate species, mediate numerous functions including cell differentiation and development, and are associated with numerous human diseases, including cardiac and...
Gap Junctions01:27

Gap Junctions

The cytoplasm of adjacent animal cells can exchange small molecules, ions, and secondary messengers via the communication channels which form the gap junctions. These junctions comprise a few hundred to thousands of molecular channels, each made of two halves, called the connexon hemichannel. A connexon is a hexamer of six transmembrane connexin proteins, which assemble radially, thus forming a pore or channel in the center. One connexon hemichannel docks with a corresponding connexon on the...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...